Vigonvita Life Sciences Co., Ltd. (HKG:2630)
Hong Kong · Delayed Price · Currency is HKD 86.45
+3.60 (4.35%)
Aug 20, 2026, 4:09 PM HKT
Vigonvita Life Sciences Market Cap
Vigonvita Life Sciences has a market cap or net worth of 14.49 billion as of August 20, 2026.
Market Cap
14.49B
Enterprise Value
14.62B
Revenue
113.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
86.45
ChartMarket Cap Chart
Since November 6, 2025, Vigonvita Life Sciences's market cap has increased from 13.74B to 14.49B, an increase of 5.43%. That is a compound annual growth rate of 6.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 14.49B | 5.62% |
| Dec 31, 2025 | 13.72B | -0.18% |
| Nov 6, 2025 | 13.74B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 310.04B |
| Hansoh Pharmaceutical Group Company | 199.71B |
| WuXi Biologics | 189.43B |
| Innovent Biologics | 166.00B |
| Duality Biotherapeutics | 16.82B |
| Angelalign Technology | 16.24B |
| Shandong Weigao Group Medical Polymer Company | 15.82B |
| Ping An Healthcare and Technology Company | 15.74B |